Sam Backenroth
2014 - Ohr Pharmaceutical
In 2014, Sam Backenroth earned a total compensation of $1.2M as Chief Financial Officer at Ohr Pharmaceutical, a 801% increase compared to previous year.
Compensation breakdown
| Option Awards | $977,192 |
|---|---|
| Salary | $177,704 |
| Other | $21,530 |
| Total | $1,176,426 |
Backenroth received $977.2K in option awards, accounting for 83% of the total pay in 2014.
Backenroth also received $177.7K in salary and $21.5K in other compensation.
Rankings
In 2014, Sam Backenroth's compensation ranked 6,868th out of 13,032 executives tracked by ExecPay. In other words, Backenroth earned more than 47.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,868 out of 13,032 | 47th |
Division Manufacturing | 2,518 out of 4,966 | 49th |
Major group Chemicals And Allied Products | 855 out of 1,686 | 49th |
Industry group Drugs | 675 out of 1,365 | 51st |
Industry Pharmaceutical Preparations | 517 out of 1,043 | 50th |
Source: SEC filing on January 28, 2015.
Backenroth's colleagues
We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2014.